The relative atherogenicity of VLDL and LDL is dependent on the topographic site

Journal of Lipid Research

Volumn 51, Issue 6, 2010, Pages 1478-1485

  Van Craeyveld, Eline ^a   Jacobs, Frank ^a   Feng, Yingmei ^a   Thomassen, Leen C J ^b   Martens, Johan A ^b   Lievens, Joke ^a   Snoeys, Jan ^a   De Geest, Bart ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Apolipoprotein E; Atherosclerosis; Familial hypercholesterolemia; LDL receptor; Lipoproteins; Rabbit; Topography

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA BIFURCATION; AORTA INTIMA; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY; HOMOZYGOSITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RABBIT; RENAL ARTERY; SEX DIFFERENCE; THORACIC AORTA; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMAL FEED; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; HETEROZYGOTE; HOMOZYGOTE; MALE; RABBITS; RECEPTORS, LDL; TUNICA INTIMA;

EID: 77952710231     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M003509     Document Type: Article

References (34)

1. Lusis, A. J. 2000. Atherosclerosis. Nature. 407: 233-241.
2. Hutter, C. M., M. A. Austin, and S. E. Humphries. 2004. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am. J. Epidemiol. 160: 430-435.
3. Twickler, T., G. M. Dallinga-Thie, M. J. Chapman, and J. S. Cohn. 2005. Remnant lipoproteins and atherosclerosis. Curr. Atheroscler. Rep. 7: 140-147.
4. Proctor, S. D., D. F. Vine, and J. C. Mamo. 2002. Arterial retention of apolipoprotein B(48)-and B(100)-containing lipoproteins in atherogenesis. Curr. Opin. Lipidol. 13: 461-470.
5. Tabas, I., K. J. Williams, and J. Boren. 2007. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 116: 1832-1844. (Pubitemid 350287108)
6. Rapp, J. H., A. Lespine, R. L. Hamilton, N. Colyvas, A. H. Chaumeton, J. Tweedie-Hardman, L. Kotite, S. T. Kunitake, R. J. Havel, and J. P. Kane. 1994. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler. Thromb. 14: 1767-1774. (Pubitemid 2164784)
7. Chung, B. H., G. Tallis, V. Yalamoori, G. M. Anantharamaiah, and J. P. Segrest. 1994. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. Arterioscler. Thromb. 14: 622-635. (Pubitemid 24116933)
8. Veniant, M. M., M. A. Sullivan, S. K. Kim, P. Ambroziak, A. Chu, M. D. Wilson, M. K. Hellerstein, L. L. Rudel, R. L. Walzem, and S. G. Young. 2000. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100. J. Clin. Invest. 106: 1501-1510.
9. Curtiss, L. K., and W. A. Boisvert. 2000. Apolipoprotein E and atherosclerosis. Curr. Opin. Lipidol. 11: 243-251.
10. Greenow, K., N. J. Pearce, and D. P. Ramji. 2005. The key role of apolipoprotein E in atherosclerosis. J. Mol. Med. 83: 329-342.
11. Majack, R. A., C. K. Castle, L. V. Goodman, K. H. Weisgraber, R. W. Mahley, E. M. Shooter, and P. J. Gebicke-Haerter. 1988. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J. Cell Biol. 107: 1207-1213.
12. Hui, D. Y. 2004. Apolipoprotein E-induced cell signaling in the vessel wall. Rev. Endocr. Metab. Disord. 5: 335-341.
13. Shimano, H., J. Ohsuga, M. Shimada, Y. Namba, T. Gotoda, K. Harada, M. Katsuki, Y. Yazaki, and N. Yamada. 1995. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J. Clin. Invest. 95: 469-476.
14. McGill, H. C., Jr., and C. A. McMahan. 1998. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am. J. Cardiol. 82: 30T-36T.
15. McGill, H. C., Jr., C. A. McMahan, and S. S. Gidding. 2008. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation. 117: 1216-1227.
16. VanderLaan, P. A., C. A. Reardon, and G. S. Getz. 2004. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler. Thromb. Vasc. Biol. 24: 12-22.
17. Methia, N., P. Andre, C. V. Denis, M. Economopoulos, and D. D. Wagner. 2001. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 98: 1424-1428.
18. Feussner, G., A. Wagner, B. Kohl, and R. Ziegler. 1993. Clinical features of type III hyperlipoproteinemia: analysis of 64 patients. Clin. Investig. 71: 362-366. (Pubitemid 23142834)
19. Kondo, T., and Y. Watanabe. 1975. [A heritable hyperlipemic rabbit (author's transl)]. Jikken Dobutsu. 24: 89-94.
20. Watanabe, Y. 1980. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis. 36: 261-268.
21. Van Craeyveld, E., J. Lievens, F. Jacobs, Y. Feng, J. Snoeys, and B. De Geest. 2009. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions. Gene Ther. 16: 757-765.
22. Sun, H., S. Usui, M. Shiomi, T. Watanabe, and J. Fan. 2002. A rapid PCR method of genotyping LDL receptor mutations in WHHL rabbits. J. Atheroscler. Thromb. 9: 145-148.
23. Junqueira, L. C., G. Bignolas, and R. R. Brentani. 1979. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 11: 447-455.
24. Havel, R. J., T. Kita, L. Kotite, J. P. Kane, R. L. Hamilton, J. L. Goldstein, and M. S. Brown. 1982. Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia. Arteriosclerosis. 2: 467-474.
25. Warren, R. J., D. L. Ebert, A. Mitchell, and P. J. Barter. 1991. Rabbit hepatic lipase cDNA sequence: low activity is associated with low messenger RNA levels. J. Lipid Res. 32: 1333-1339.
26. Kovanen, P. T., M. S. Brown, S. K. Basu, D. W. Bilheimer, and J. L. Goldstein. 1981. Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc. Natl. Acad. Sci. USA. 78: 1396-1400.
27. Herijgers, N., M. Van Eck, P. H. Groot, P. M. Hoogerbrugge, and T. J. Van Berkel. 1997. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice. Arterioscler. Thromb. Vasc. Biol. 17: 1995-2003. (Pubitemid 28057100)
28. O'Brien, K. D., S. S. Deeb, M. Ferguson, T. O. McDonald, M. D. Allen, C. E. Alpers, and A. Chait. 1994. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am. J. Pathol. 144: 538-548.
29. Yla-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, I. J. Goldberg, D. Steinberg, and J. L. Witztum. 1991. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88: 10143-10147. (Pubitemid 21915791)
30. Spagnoli, L. G., A. Orlandi, A. Mauriello, G. Santeusanio, C. de Angelis, R. Lucreziotti, and M. T. Ramacci. 1991. Aging and atherosclerosis in the rabbit. 1. Distribution, prevalence and morphology of atherosclerotic lesions. Atherosclerosis. 89: 11-24.
31. Proctor, S. D., and J. C. Mamo. 2003. Intimal retention of cholesterol derived from apolipoprotein B100-and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. Vasc. Biol. 23: 1595-1600.
32. Yamada, N., D. M. Shames, J. B. Stoudemire, and R. J. Havel. 1986. Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: heterogeneity related to the presence of apolipoprotein E. Proc. Natl. Acad. Sci. USA. 83: 3479-3483. (Pubitemid 16043061)
33. Yoon, T. H., N. Mori, K. Kitamura, S. Ishibashi, H. Shimano, H. Mokuno, T. Gotoda, F. Takaku, and N. Yamada. 1991. Characterization of monoclonal anti-rabbit apolipoprotein E antibodies and chemical composition of lipoproteins separated by anti-apolipoprotein E immuno-affinity chromatography. J. Biochem. 109: 204-210.
34. Havel, R. J., L. Kotite, J. L. Vigne, J. P. Kane, P. Tun, N. Phillips, and G. C. Chen. 1980. Radioimmunoassay of human arginine-rich apolipoprotein, apoprotein E. Concentration in blood plasma and lipoproteins as affected by apoprotein E-3 deficiency. J. Clin. Invest. 66: 1351-1362.